Developer docs
API playgroundTry for free, no card

Search company profiles

Micron

Full company profile

uuid000akc6

Namestring
Micron
Legal namestring
Micron Technology, Inc.
Websiteurl
micron-kobe.com
Company typeenum
Public
Founded yearint
1978
Descriptiontext

Micron Technology, Inc. is a US-headquartered semiconductor memory manufacturer founded in 1978 and headquartered in Boise, Idaho. The company produces DRAM (including DDR4, DDR5, and LPDDR4), NAND flash, and High-Bandwidth Memory (HBM) products sold to AI hyperscalers, OEMs, automotive, defense, industrial, networking, and consumer electronics customers. Micron is one of only three companies—alongside Samsung and SK Hynix—controlling approximately 90% of the DRAM market, and is the sole US-headquartered major DRAM producer.

The company's technology stack is built on proprietary 1α (1-alpha) nm DRAM process technology and G9 NAND architecture. Its current-generation offerings include HBM3E memory certified for NVIDIA AI accelerators, the 245TB Micron 6600 ION SSD (purported to be the world's highest-capacity commercially available SSD), and 256GB DDR5 RDIMM server modules. Manufacturing operations span Idaho (headquarters and new fab), Virginia (the Fab 6 facility, now producing 1α nm DRAM— the most advanced DRAM ever domestically manufactured in the United States), New York (megafab under construction in Clay), and Taiwan, supported by a $200 billion US investment plan and over $25 billion in projected FY2026 capex, with $275 million in CHIPS and Science Act funding backing the Virginia expansion.

Revenue is generated primarily through direct hardware sales to hyperscale cloud operators (Google, Microsoft, Amazon, Meta) under multi-year contracts, supplemented by OEM embedding through server and storage system builders (Dell Technologies) and ecosystem partnerships with AI chip designers (NVIDIA, Marvell). In Q2 FY2026, Micron reported $23.86 billion in revenue (up 196% year-over-year), 74.9% non-GAAP gross margin (with Q3 guidance of 81%), and approximately $38 billion in projected FY2026 free cash flow—figures that drove the stock above a $1 trillion market capitalization for the first time on May 26, 2026.

Short descriptiontext

Micron Technology, Inc. is a US-headquartered semiconductor memory manufacturer producing DRAM, NAND, and High-Bandwidth Memory (HBM) chips for AI hyperscalers, OEMs, and long-lifecycle automotive and defense customers. Q2 FY2026 revenue reached $23.86 billion, nearly tripling year-on-year, with the stock reaching a $1 trillion market cap in May 2026.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersTokyo, Japan
HQ citystring
Tokyo
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
imaging CRO services, clinical trial imaging, theranostics development, SaMD regulatory support, medical device distribution
Industry2 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Services (Imaging CRO)
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1DRAM (Dynamic Random-Access Memory)
TypeHardware Sales
Description

Primary revenue driver including DDR4, DDR5, LPDDR4 for data center, automotive, defense, networking, and consumer applications. Q2 FY2026 DRAM ASP rose 60% quarter-on-quarter. Micron is the only US-headquartered DRAM maker. Revenue was $23.86B in Q2 FY2026, nearly triple year-ago levels of $8.05B.

panewslab.com
2NAND Flash Memory
TypeHardware Sales
Description

NAND flash products including enterprise SSDs for AI server infrastructure. Micron and SanDisk are tied at ~$5.95B in NAND revenue for Q1 2026 per TrendForce. Supply shortages expected to persist through 2026.

trendforce.com
3High-Bandwidth Memory (HBM)
TypeHardware Sales
Description

Premium AI-specific memory with NVIDIA certification, fully sold out through 2026. HBM gross margins reached ~66%+ (Cloud Memory segment). Five-year HBM sales agreements with hyperscalers provide revenue visibility.

panewslab.com
4Enterprise SSD Solutions
TypeHardware Sales
Description

Data center SSDs including the 245TB Micron 6600 ION shipping to customers including Dell Technologies. Positioned as HDD replacement for AI and hyperscale environments.

in.investing.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details3 tiers
1Micron 256GB DDR5 RDIMM — high-density server memory module
ModelUnit PricingBilling cadenceMulti-year contract
Notes

High price point exceeding $2,000 per unit, creating a barrier for smaller operators while offering long-term power efficiency savings for hyperscalers. Premium pricing reflects severe supply constraints and AI-driven demand.

techgenyz.com
2HBM (High-Bandwidth Memory) — AI-specific memory chips
ModelUnit PricingBilling cadenceMulti-year contract
Notes

HBM prices potentially rising 70–100%. Fully sold out through 2026. Long-term supply agreements with hyperscalers lock in pricing for 5-year terms. Spot market unavailable.

seekingalpha.com
3Micron 6600 ION SSD (245TB) — data center storage
ModelUnit PricingBilling cadenceAnnual
Notes

Cost up to 22.6x higher per terabyte than traditional HDDs, but positioned as total cost of ownership reduction for AI data centers. Dell Technologies has indicated incorporation of the drive.

blocksandfiles.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Crucial
Description

Consumer memory products brand (though recent reports indicate Micron has shut down Crucial brand operations)

cnbc.com
Core offering1 text field

Micron (株式会社マイクロン) is an Asia-based imaging Contract Research Organization (CRO) providing clinical trial imaging services, theranostics development support, SaMD (Software as a Medical Device) development, regulatory consultation, clinical development support, and medical device distribution for pharmaceutical, biotech, and medical device companies. The company specializes in imaging biomarker development and standardization across clinical trial phases, with more than 20 years of experience serving 270+ client companies and academic institutions across 20+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 84x better energy efficiency and 8.6x faster AI preprocessing vs HDDs with Micron 6600 ION 245TB SSD
+6 more records
Product and service10 records
1Imaging CRO Services
CategoryImaging CRO
Description

Global imaging CRO services for clinical trials, leveraging deep expertise across multiple imaging modalities to support trial design, operations, and standardized image evaluation for pharmaceutical and medical device sponsors.

2Theranostics Development Support
CategoryClinical Development
Description

End-to-end development support for radio-pharmaceutical theranostics, integrating manufacturing, clinical development, and image evaluation into a single workflow for sponsors in the radiopharmaceutical space.

3SaMD Development Support
CategoryMedical Device Regulatory
Description

Development support for AI/ML-driven Software as a Medical Device programs, including regulatory strategy, clinical evaluation, approval and certification submission, and Marketing Authorization Holder (MAH) system setup for diagnostic and therapeutic device sponsors.

4Clinical Development Support
CategoryClinical Development
Description

Comprehensive clinical development support covering trial planning, execution, and progress management, balancing quality and speed to ensure reliable trial operations for pharmaceutical and medical device sponsors.

5Regulatory Consultation Services
CategoryRegulatory Affairs
Description

Regulatory affairs consultation for pharmaceutical and medical device development, supporting sponsors with strategy and submission preparation across Japanese and global approval pathways.

6Quality Management System (QMS) Services
CategoryQuality Management
Description

Quality management system consulting and operational support for pharmaceutical, medical device, and SaMD development programs, ensuring compliance with applicable quality standards.

7Medical Device Sales and Distribution
CategoryMedical Device Distribution
Description

Sales and distribution of medical devices including image analysis software, professional and home-use medical devices, and femtech products addressing women's health and broader medical and healthcare needs.

8INDICATE Diagnostic and Therapeutic Bridging Support
CategoryImaging CRO
Description

Support service bridging diagnostics and therapeutics, including AI-powered brain MRA image analysis software, designed to connect diagnostic imaging insights with therapeutic development and clinical decision-making.

9MAH / DMAH Services
CategoryRegulatory Affairs
Description

Marketing Authorization Holder and Designated Marketing Authorization Holder services enabling foreign and domestic sponsors to obtain and operate Japan market authorization, including sales and market introduction support.

10Investigational Drug GMP Development Support
CategoryClinical Development
Description

Support for building investigational drug GMP-compliant manufacturing and supply systems tailored to imaging clinical trials, including radio-pharmaceutical and other imaging agent development.

Scale indicator17 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-05-29
Description

Micron is listed as a strategic infrastructure partner in Anthropic's historic $65 billion Series H funding round, which pushed Anthropic's valuation to $965 billion. The round was co-led by Altimeter Capital, Dragoneer, Greenoaks, Sequoia Capital, Capital Group, Coatue, D1 Capital Partners, GIC, ICONIQ, and XN. Micron provides memory chips for Anthropic's AI compute infrastructure as part of the strategic partnership.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-26
Description

Marvell Technology is building custom HBM architecture in collaboration with Micron, SK Hynix, and Samsung, positioning Marvell as a beneficiary of the sustained memory undersupply (30–50% through 2026–2027) and HBM price increases. Micron's HBM supply relationship with Marvell is part of the broader AI memory ecosystem integration.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-09
Description

Micron achieved NVIDIA HBM3E certification for supply to NVIDIA AI accelerators, entering the AI computing infrastructure ecosystem. This certification validates Micron's HBM quality and performance for the leading AI GPU platform. Micron's HBM is fully sold out through 2026. NVIDIA CEO Jensen Huang's comments about being in the early stages of the AI revolution have influenced Micron's stock performance.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-08
Description

Applied Materials partnered with Micron to develop next-generation memory for AI applications. This collaboration leverages Applied Materials' deposition and etching expertise with Micron's memory design and process capabilities to advance AI-specific memory technology. Applied Materials also signed a definitive agreement to acquire NEXX from ASMPT Limited to expand its advanced packaging portfolio.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-05
Description

Dell Technologies has indicated it will incorporate the Micron 6600 ION 245TB SSD into its data center product lineup. The SSD is positioned as a meaningful total cost of ownership reduction for AI and large-scale data center environments compared to traditional HDD storage.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers7 records
TypeDirect peer
Description

Japan-based CRO offering clinical trial management, data management, and biostatistics services. Comparable mid-sized Japanese CRO competitor with overlapping sponsor base and clinical development capabilities.

TypeDirect peer
Description

Specialty imaging CRO focused on independent imaging review and AI-driven imaging biomarker analysis for oncology and other therapeutic trials. Comparable to Micron's specialty positioning in imaging endpoints, with larger oncology franchise.

TypeDirect peer
Description

Global clinical trial technology and imaging CRO offering imaging management, eCOA, and decentralized trial solutions. Comparable to Micron as an imaging-specialized CRO, with much broader scale and technology platform.

TypeDirect peer
Description

Imaging-focused CRO providing independent imaging review, image management, and biomarker services for clinical trials globally. Directly comparable to Micron's core imaging CRO service line, though serving primarily US/EU sponsors.

TypeDirect peer
Description

Japan's largest domestic CRO, offering full-service clinical development, MAH/DMAH services, and site management. Directly comparable to Micron as a Japan-headquartered CRO serving pharmaceutical and medical device sponsors, though at significantly larger scale.

TypeDirect peer
Description

Japanese CRO group providing clinical development, SMO, and consulting services to pharma sponsors. Comparable to Micron in domestic positioning, with broader service lines including site management organization operations.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Micron

Clinical Research Services (Imaging CRO)micron-kobe.com

Micron Technology, Inc. is a US-headquartered semiconductor memory manufacturer producing DRAM, NAND, and High-Bandwidth Memory (HBM) chips for AI hyperscalers, OEMs, and long-lifecycle automotive and defense customers. Q2 FY2026 revenue reached $23.86 billion, nearly tripling year-on-year, with the stock reaching a $1 trillion market cap in May 2026.

What Micron does

Micron Technology, Inc. is a US-headquartered semiconductor memory manufacturer founded in 1978 and headquartered in Boise, Idaho. The company produces DRAM (including DDR4, DDR5, and LPDDR4), NAND flash, and High-Bandwidth Memory (HBM) products sold to AI hyperscalers, OEMs, automotive, defense, industrial, networking, and consumer electronics customers. Micron is one of only three companies—alongside Samsung and SK Hynix—controlling approximately 90% of the DRAM market, and is the sole US-headquartered major DRAM producer.

The company's technology stack is built on proprietary 1α (1-alpha) nm DRAM process technology and G9 NAND architecture. Its current-generation offerings include HBM3E memory certified for NVIDIA AI accelerators, the 245TB Micron 6600 ION SSD (purported to be the world's highest-capacity commercially available SSD), and 256GB DDR5 RDIMM server modules. Manufacturing operations span Idaho (headquarters and new fab), Virginia (the Fab 6 facility, now producing 1α nm DRAM— the most advanced DRAM ever domestically manufactured in the United States), New York (megafab under construction in Clay), and Taiwan, supported by a $200 billion US investment plan and over $25 billion in projected FY2026 capex, with $275 million in CHIPS and Science Act funding backing the Virginia expansion.

Revenue is generated primarily through direct hardware sales to hyperscale cloud operators (Google, Microsoft, Amazon, Meta) under multi-year contracts, supplemented by OEM embedding through server and storage system builders (Dell Technologies) and ecosystem partnerships with AI chip designers (NVIDIA, Marvell). In Q2 FY2026, Micron reported $23.86 billion in revenue (up 196% year-over-year), 74.9% non-GAAP gross margin (with Q3 guidance of 81%), and approximately $38 billion in projected FY2026 free cash flow—figures that drove the stock above a $1 trillion market capitalization for the first time on May 26, 2026.

Micron firmographics

Firmographics
Name
Micron
Legal name
Micron Technology, Inc.
Website
https://micron-kobe.com
Company type
Public
Founded year
1978
Operating status
Operating
Headcount range
101–250 employees
Short description
Micron Technology, Inc. is a US-headquartered semiconductor memory manufacturer producing DRAM, NAND, and High-Bandwidth Memory (HBM) chips for AI hyperscalers, OEMs, and long-lifecycle automotive and defense customers. Q2 FY2026 revenue reached $23.86 billion, nearly tripling year-on-year, with the stock reaching a $1 trillion market cap in May 2026.
Ownership category
akta.pro rank

Micron industry classification

Industry
Product category
Clinical Research Services (Imaging CRO)
NAICS
Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)

Keywords

  • Imaging CRO services
  • Clinical trial imaging
  • Theranostics development
  • SaMD regulatory support
  • Medical device distribution

Where Micron is headquartered

Location

Headquarters

HQ city
Tokyo
HQ country
Japan
HQ region
Asia

Offices6 records

Markets served

Micron business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. DRAM (Dynamic Random-Access Memory): Primary revenue driver including DDR4, DDR5, LPDDR4 for data center, automotive, defense, networking, and consumer applications. Q2 FY2026 DRAM ASP rose 60% quarter-on-quarter. Micron is the only US-headquartered DRAM maker. Revenue was $23.86B in Q2 FY2026, nearly triple year-ago levels of $8.05B.
  2. NAND Flash Memory: NAND flash products including enterprise SSDs for AI server infrastructure. Micron and SanDisk are tied at ~$5.95B in NAND revenue for Q1 2026 per TrendForce. Supply shortages expected to persist through 2026.
  3. High-Bandwidth Memory (HBM): Premium AI-specific memory with NVIDIA certification, fully sold out through 2026. HBM gross margins reached ~66%+ (Cloud Memory segment). Five-year HBM sales agreements with hyperscalers provide revenue visibility.
  4. Enterprise SSD Solutions: Data center SSDs including the 245TB Micron 6600 ION shipping to customers including Dell Technologies. Positioned as HDD replacement for AI and hyperscale environments.

Pricing tiers

ModelBillingPrice
Unit PricingMulti-year contractMicron 256GB DDR5 RDIMM — high-density server memory module
Unit PricingMulti-year contractHBM (High-Bandwidth Memory) — AI-specific memory chips
Unit PricingAnnualMicron 6600 ION SSD (245TB) — data center storage

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

Micron product offering

Product offering

Core offering

Micron (株式会社マイクロン) is an Asia-based imaging Contract Research Organization (CRO) providing clinical trial imaging services, theranostics development support, SaMD (Software as a Medical Device) development, regulatory consultation, clinical development support, and medical device distribution for pharmaceutical, biotech, and medical device companies. The company specializes in imaging biomarker development and standardization across clinical trial phases, with more than 20 years of experience serving 270+ client companies and academic institutions across 20+ countries.

Differentiator

Problem solved

Functional benefit

Brands

  • Crucial: Consumer memory products brand (though recent reports indicate Micron has shut down Crucial brand operations)

Products and services

  • Imaging CRO Services Global imaging CRO services for clinical trials, leveraging deep expertise across multiple imaging modalities to support trial design, operations, and standardized image evaluation for pharmaceutical and medical device sponsors.
  • Theranostics Development Support End-to-end development support for radio-pharmaceutical theranostics, integrating manufacturing, clinical development, and image evaluation into a single workflow for sponsors in the radiopharmaceutical space.
  • SaMD Development Support Development support for AI/ML-driven Software as a Medical Device programs, including regulatory strategy, clinical evaluation, approval and certification submission, and Marketing Authorization Holder (MAH) system setup for diagnostic and therapeutic device sponsors.
  • Clinical Development Support Comprehensive clinical development support covering trial planning, execution, and progress management, balancing quality and speed to ensure reliable trial operations for pharmaceutical and medical device sponsors.
  • Regulatory Consultation Services Regulatory affairs consultation for pharmaceutical and medical device development, supporting sponsors with strategy and submission preparation across Japanese and global approval pathways.
  • Quality Management System (QMS) Services Quality management system consulting and operational support for pharmaceutical, medical device, and SaMD development programs, ensuring compliance with applicable quality standards.
  • Medical Device Sales and Distribution Sales and distribution of medical devices including image analysis software, professional and home-use medical devices, and femtech products addressing women's health and broader medical and healthcare needs.
  • INDICATE Diagnostic and Therapeutic Bridging Support Support service bridging diagnostics and therapeutics, including AI-powered brain MRA image analysis software, designed to connect diagnostic imaging insights with therapeutic development and clinical decision-making.
  • MAH / DMAH Services Marketing Authorization Holder and Designated Marketing Authorization Holder services enabling foreign and domestic sponsors to obtain and operate Japan market authorization, including sales and market introduction support.
  • Investigational Drug GMP Development Support Support for building investigational drug GMP-compliant manufacturing and supply systems tailored to imaging clinical trials, including radio-pharmaceutical and other imaging agent development.

Quantifiable outcome

  • 84x better energy efficiency and 8.6x faster AI preprocessing vs HDDs with Micron 6600 ION 245TB SSD
  • +6 more outcomes

Companies that use Micron

Customer profile

Named customers10 records

Segments4 records

Ideal customer profiles2 records

Micron technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Micron partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered major and core.

  • AnthropicmajorStrategic or Co-development Partner · 29 May 2026Micron is listed as a strategic infrastructure partner in Anthropic's historic $65 billion Series H funding round, which pushed Anthropic's valuation to $965 billion. The round was co-led by Altimeter Capital, Dragoneer, Greenoaks, Sequoia Capital, Capital Group, Coatue, D1 Capital Partners, GIC, ICONIQ, and XN. Micron provides memory chips for Anthropic's AI compute infrastructure as part of the strategic partnership.
  • Marvell TechnologycoreTechnology or Integration · 26 May 2026Marvell Technology is building custom HBM architecture in collaboration with Micron, SK Hynix, and Samsung, positioning Marvell as a beneficiary of the sustained memory undersupply (30–50% through 2026–2027) and HBM price increases. Micron's HBM supply relationship with Marvell is part of the broader AI memory ecosystem integration.
  • NVIDIAcoreTechnology or Integration · 9 May 2026Micron achieved NVIDIA HBM3E certification for supply to NVIDIA AI accelerators, entering the AI computing infrastructure ecosystem. This certification validates Micron's HBM quality and performance for the leading AI GPU platform. Micron's HBM is fully sold out through 2026. NVIDIA CEO Jensen Huang's comments about being in the early stages of the AI revolution have influenced Micron's stock performance.
  • Applied MaterialscoreTechnology or Integration · 8 May 2026Applied Materials partnered with Micron to develop next-generation memory for AI applications. This collaboration leverages Applied Materials' deposition and etching expertise with Micron's memory design and process capabilities to advance AI-specific memory technology. Applied Materials also signed a definitive agreement to acquire NEXX from ASMPT Limited to expand its advanced packaging portfolio.
  • Dell TechnologiescoreTechnology or Integration · 5 May 2026Dell Technologies has indicated it will incorporate the Micron 6600 ION 245TB SSD into its data center product lineup. The SSD is positioned as a meaningful total cost of ownership reduction for AI and large-scale data center environments compared to traditional HDD storage.

Scale indicators17 records

Recent moves7 records

Expansion highlights6 records

Micron competitors and assessment

Company assessment

Peers

Direct peers

  • A2 Healthcare Corporation: Japan-based CRO offering clinical trial management, data management, and biostatistics services. Comparable mid-sized Japanese CRO competitor with overlapping sponsor base and clinical development capabilities.
  • Imaging Endpoints: Specialty imaging CRO focused on independent imaging review and AI-driven imaging biomarker analysis for oncology and other therapeutic trials. Comparable to Micron's specialty positioning in imaging endpoints, with larger oncology franchise.
  • Clario (formerly Bioclinica): Global clinical trial technology and imaging CRO offering imaging management, eCOA, and decentralized trial solutions. Comparable to Micron as an imaging-specialized CRO, with much broader scale and technology platform.
  • WorldCare Clinical: Imaging-focused CRO providing independent imaging review, image management, and biomarker services for clinical trials globally. Directly comparable to Micron's core imaging CRO service line, though serving primarily US/EU sponsors.
  • CMIC Group: Japan's largest domestic CRO, offering full-service clinical development, MAH/DMAH services, and site management. Directly comparable to Micron as a Japan-headquartered CRO serving pharmaceutical and medical device sponsors, though at significantly larger scale.
  • EPS Holdings: Japanese CRO group providing clinical development, SMO, and consulting services to pharma sponsors. Comparable to Micron in domestic positioning, with broader service lines including site management organization operations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Micron social profiles

Digital presence

Micron financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Micron leadership team

Management profile

Number of profiles

Profiles1 record

Micron funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Micron M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Micron

What does Micron do?

Micron (株式会社マイクロン) is an Asia-based imaging Contract Research Organization (CRO) providing clinical trial imaging services, theranostics development support, SaMD (Software as a Medical Device) development, regulatory consultation, clinical development support, and medical device distribution for pharmaceutical, biotech, and medical device companies. The company specializes in imaging biomarker development and standardization across clinical trial phases, with more than 20 years of experience serving 270+ client companies and academic institutions across 20+ countries.

Is Micron a public or private company?

Micron is a public company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Micron founded?

Micron was founded in 1978. It employs 101 to 250 people.

Where is Micron based?

Micron is headquartered in Tokyo, Japan, in the Asia region.

How does Micron make money?

Four revenue lines are on record. DRAM (Dynamic Random-Access Memory) is the primary driver. The others are NAND Flash Memory, high-Bandwidth Memory (HBM) and enterprise SSD Solutions.

Who are Micron's main competitors?

IXICO plc is listed as a peer. Direct peers are A2 Healthcare Corporation, Imaging Endpoints, Clario (formerly Bioclinica), WorldCare Clinical, CMIC Group and EPS Holdings.

Does Micron have an API?

No public API is recorded for Micron.

What industry is Micron in?

Micron's product category is Clinical Research Services (Imaging CRO). Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
KauppalehtiJukka Lepikkö kehuu yli 90 prosentin vuosituotolla â Kysyimme, mitä salkku sisältääInvestor Jukka Lepikkö reported a portfolio return of over 90% for the year, driven primarily by active trading in artificial intelligence-related stocks such as Micron and Nvidia. He maintains an optimistic outlook on the semiconductor sector, dismissing concerns about an AI bubble due to reasonable valuation metrics relative to historical averages.Yahoo5-star analyst sets jaw-dropping Micron stock price target for 2026New Street analyst Pierre Ferragu upgraded Micron stock to Buy with a $1,250 price target, arguing that AI-driven demand for High Bandwidth Memory (HBM) is breaking the traditional volatile boom-and-bust cycle of the memory industry. The report highlights that HBM is becoming an indispensable component for major tech giants like Nvidia and Google, leading to structural changes in market dynamics and valuation premiums. This analysis comes as Micron's shares have surged significantly this year amid tight supply conditions.Tech TimesSwitch 2 Price Warning Hits Retail Kiosks: September 1 Deadline Now UnavoidableNintendo will increase the US retail price of the Switch 2 from $449.99 to $499.99 on September 1, coinciding with the expiration of its current "Choose Your Game" bundle. This price hike is driven by rising costs for LPDDR5X memory chips, as manufacturers Samsung, SK Hynix, and Micron have shifted production capacity toward higher-margin High Bandwidth Memory used in AI accelerators. Nintendo has implemented in-store kiosk warnings at retailers like Walmart to inform consumers of the impending change two weeks before it takes effect.CNBCHere's a rapid-fire update on our 32-stock portfolio, including Cramer's 5 favorites to buyJim Cramer and portfolio director Jeff Marks discussed their 32-stock portfolio during the CNBC Investing Club's August Monthly Meeting, emphasizing five favorite stocks to buy, including Nvidia, Micron, and Intel, amidst a resurgence in the artificial intelligence sector. They also reviewed recent exits from stocks like Nike and Honeywell Aerospace, indicating active management of the portfolio. The session highlighted strategic insights into market dynamics and stock selections related to AI.DIGITIMES AsiaHanmi pulls ahead of Hanwha as HBM4 orders reboundSouth Korea's Hanmi Semiconductor is gaining market share over rival Hanwha Semitech in thermal compression bonders for high-bandwidth memory as HBM4 equipment orders rebound. This shift is driven by Hanmi's growing business with Micron, which helps reduce its reliance on SK Hynix.Investing.comNetlist stock surges after filing ITC complaint against Micron By Investing.comNetlist Inc. filed a patent infringement complaint against Micron and other technology companies with the United States International Trade Commission, which caused its stock to rise 14.5%. The complaint seeks exclusion and cease and desist orders based on alleged infringement of four Netlist patents related to DDR5 RDIMMs and MRDIMMs. Netlist's action highlights ongoing disputes over technology licenses in the industry.YahooNetlist Files Patent Infringement Action Against Micron at U.S. International Trade CommissionNetlist has filed patent infringement proceedings against Micron, Supermicro, HPE, and Lenovo at the U.S. International Trade Commission, seeking to block memory products accused of infringement from entering the U.S. The company is requesting exclusion and cease and desist orders related to four specific patents concerning DDR5 RDIMMs and MRDIMMs. The ITC proceedings are expedited, and the outcomes could significantly impact the import of technology products linked to these patents.WccftechCXMT Hits 90% Yield on 17nm DDR5 Chips, Closing the Gap With Micron & Others – ReportChinese memory manufacturer CXMT has achieved a 90% yield rate for its 17nm DDR5 chips, enabling increased production volumes amid high local demand. Major PC manufacturers Acer and ASUS have begun incorporating these chips into products sold in Mainland China and emerging markets, while US firms like Dell and HP maintain restrictive policies due to geopolitical concerns. This progress allows CXMT to close the technological gap with global leaders such as Micron, SK hynix, and Samsung, although it continues to face limitations from US sanctions on advanced lithography equipment.247wallstElon Musk’s Newest Factory is 15X The Size of The Pentagon. Micron and Memory Stocks Should be Terrified.SpaceX released renderings of the Terrafab facility, a 100 million square foot semiconductor manufacturing plant designed to break the oligopoly held by Micron, SK Hynix, and Samsung. The article contrasts the investment profiles of Micron Technology and Lam Research, noting that while Micron faces potential pricing pressure from new competition, Lam stands to benefit from equipment sales associated with the massive capital expenditure projected for Terrafab.The Motley FoolMicron Stock Is Down 28%, and Here Is What Investors Need to KnowMicron's stock has declined by approximately 28% from its June peak, driven by weaker-than-expected guidance and profit-taking despite the company's strong position in the AI memory market. The semiconductor giant remains a key supplier for data centers, benefiting from high gross margins amid supply constraints that have not yet caught up with demand. Analysts view the pullback as a temporary volatility event within a broader cyclical high rather than a fundamental shift in the company's long-term trajectory.